Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
Registry
1 other identifier
observational
300
1 country
3
Brief Summary
Proton therapy is a limited medical resource that is more expensive than conventional x-ray therapy. To correctly measure the success of proton therapy in treating different conditions, it is important to check a patient's health status after their treatment is finished. Checking on the progress of patients over many years (called long-term follow-up) is needed because the long-term effects of proton therapy are not well known.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2013
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 14, 2014
CompletedFirst Posted
Study publicly available on registry
February 25, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2050
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2050
February 8, 2023
February 1, 2023
36.1 years
January 14, 2014
February 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Long-term follow-up
Maintaining regular, lifetime contact with subjects in order to obtain current identification , contact information, and self/parent-reported health status in order to obtain a better understanding of overall treatment strategies and patient benefits of treatment.
6 months
Secondary Outcomes (1)
Future Research Possibilities
12 months
Study Arms (1)
Radiation therapy Registry
Cancer patients who have received proton therapy
Interventions
Eligibility Criteria
Patients who are seen/treated at proton therapy centers
You may qualify if:
- All subjects who are receiving or seeking medical care at the participating Proton Therapy Center will be invited to participate in the Research Registry.
You may not qualify if:
- Subjects who do not agree to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Ackerman Cancer Center
Jacksonville, Florida, 32223, United States
Provision CARES Proton Therapy Nashville
Franklin, Tennessee, 37067, United States
Texas Center for Proton Therapy
Irving, Texas, 75063, United States
Related Links
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James R Gray, M.D.
Provision Center for Proton Therapy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 25 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2014
First Posted
February 25, 2014
Study Start
December 1, 2013
Primary Completion (Estimated)
January 1, 2050
Study Completion (Estimated)
January 1, 2050
Last Updated
February 8, 2023
Record last verified: 2023-02